Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Expanded Access to Belantamab Mafodotin for a Single Patient with Relapsed/Refractory Multiple Myeloma

Disease Sites:

Not Available

Staging:

N/A

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Dholaria, Bhagirathbhai

Scope:

Local

Participating Institutions:

Vanderbilt University

Open Date:

03-14-2023

Trial Type:

Treatment

Protocol ID:

VICC-XVPCL23219

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available